- Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion
-
Ha J, Cheong JW, Shin S, Lee ST, Choi JR
- KMID: 2373546
- Ann Lab Med.
- 2016 May;36(3):287-289.
- doi: 10.3343/alm.2016.36.3.287
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case with Coexistence of Major and Minor BCR/ABL Fusion Transcript at Lymphoblastic Crisis of Chronic Myelogenous Leukemia in Patients with Major BCR/ABL Positivity during Chronic Phase
-
Park SH, Chi HS, Cho YU, Jang S, Park CJ, Im HJ
- KMID: 1781303
- Ann Lab Med.
- 2013 Jan;33(1):80-83.
- doi: 10.3343/alm.2013.33.1.80
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Concurrence of e1a2 and e19a2 BCR-ABL1 Fusion Transcripts in a Typical Case of Chronic Myeloid Leukemia
-
Lee J, Kim DS, Lee HS, Choi SI, Cho YG
- KMID: 2373619
- Ann Lab Med.
- 2017 Jan;37(1):74-76.
- doi: 10.3343/alm.2017.37.1.74
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Rare Frameshift Mutation Cys475Tyrfs*11 in the BCR/ABL Kinase Domain Contributes to Imatinib Mesylate Resistance in 2 Korean Patients with Chronic Myelogenous Leukemia
-
Park SH, Chi HS, Kwon MR, Cho YU, Jang S, Park CJ
- KMID: 2434491
- Ann Lab Med.
- 2012 Nov;32(6):452-454.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Development of Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia
-
Kim H
- KMID: 2168203
- Hanyang Med Rev.
- 2012 May;32(2):103-111.
- doi: 10.7599/hmr.2012.32.2.103
Chronic myeloid leukemia (CML) is a malignant disease induced by the oncogenic signal of the BCRABL transcript resulting from the translocation between chromosome 9 and 22, t (9:22). This genetic... -
- CITED
-
- Close
- SHARE
-
- Close
- Two Cases of Myeloproliferative Neoplasm with a Concurrent JAK2V617F Mutation and BCR/ABL Translocation without Chronic Myelogenous Leukemia Phenotype Acquisition during Hydroxyurea Treatment
-
Park SH, Chi HS, Cho YU, Jang S, Park CJ, Kim DY, Lee JH, Lee KH
- KMID: 1781334
- Ann Lab Med.
- 2013 May;33(3):229-232.
- doi: 10.3343/alm.2013.33.3.229
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Concomitant AID Expression and BCL7A Loss Associates With Accelerated Phase Progression and Imatinib Resistance in Chronic Myeloid Leukemia
-
Yu N, Shin S, Choi JR, Kim Y, Lee KA
- KMID: 2373641
- Ann Lab Med.
- 2017 Mar;37(2):177-179.
- doi: 10.3343/alm.2017.37.2.177
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of a new flow cytometry based method for detection of BCR-ABL1 fusion protein in chronic myeloid leukemia
-
Dasgupta S, Ray UK, Mitra AG, Bhattacharyya DM, Mukhopadhyay A, Das P, Gangopadhyay S, Roy S, Mukhopadhyay S
- KMID: 2413328
- Blood Res.
- 2017 Jun;52(2):112-118.
- doi: 10.5045/br.2017.52.2.112
BACKGROUND: Philadelphia chromosome, a hallmark of chronic myeloid leukemia (CML), plays a key role in disease pathogenesis. It reflects a balanced reciprocal translocation between long arms of chromosomes 9 and... -
- CITED
-
- Close
- SHARE
-
- Close
- A Rare Case of Chronic Myelogenous Leukemia and Plasma Cell Myeloma in the Same Patient
-
Ahn S, Park JS, Han JH, Cho SR
- KMID: 2363213
- Ann Lab Med.
- 2015 May;35(3):370-372.
- doi: 10.3343/alm.2015.35.3.370
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Persistent suboptimal molecular response in a patient with chronic myelogenous leukemia and Klinefelter syndrome
-
Chakraborty R, Mukkamalla SKR, Singam K, Calderon N
- KMID: 2070143
- Korean J Intern Med.
- 2014 Nov;29(6):827-829.
- doi: 10.3904/kjim.2014.29.6.827
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Drug Eruption with Localized ExfoliativeDermatitis Induced by Imatinib Mesylate
-
Yoo KH, Rho YK, Kim JY, Li K, Seo SJ, Hong CK
- KMID: 2248087
- Korean J Dermatol.
- 2008 Oct;46(10):1435-1438.
Imatinib mesylate (Gleevec(R), formerly known as STI571) is a protein-tyrosine kinase inhibitor that inhibits the bcr-abl tyrosine kinase created by the Philadelphia chromosome abnormality in patients with chronic myeloid leukemia... -
- CITED
-
- Close
- SHARE
-
- Close
- Four Cases of Chronic Myelogenous Leukemia in Mixed Phenotype Blast Phase at Initial Presentation Mimicking Mixed Phenotype Acute Leukemia with t(9;22)
-
Choi W, Kim M, Lim J, Han K, Lee S, Lee JW, Chung NG, Kim Y
- KMID: 1781362
- Ann Lab Med.
- 2014 Jan;34(1):60-63.
- doi: 10.3343/alm.2014.34.1.60
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Two Cases of Acute Lymphoblastic Leukemia with an e1a3 BCR-ABL1 Fusion Transcript
-
Shin SY, Cho JH, Kim HJ, Jang JH, Lee ST, Kim SH
- KMID: 2363168
- Ann Lab Med.
- 2015 Jan;35(1):159-161.
- doi: 10.3343/alm.2015.35.1.159
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Detection of single nucleotide insertion of BCR/ABL region in imatinib-resistant human myelogenous leukemia SR-1 cells
-
Park TH, Kwon HC, Kim HJ, Han JY, Jeong JS, Han H, Seo CY, Kwak JY, Park JI
- KMID: 1089462
- Exp Mol Med.
- 2005 Oct;37(5):507-511.
Imatinib mesylate is a selective Bcr/Abl kinase inhibitor and an effective anticancer agent for Bcr/Abl-positive chronic myelogenous leukemia. Most patients in chronic phase maintain durable responses; however, many in blast... -
- CITED
-
- Close
- SHARE
-
- Close
- Mutational Analysis of SH2B3 in Korean Patients With BCR-ABL1 Negative Myeloproliferative Neoplasm
-
Kim N, Kim IS, Chang CL, Lee EY, Kim HH, Song MK, Shin HJ, Chung JS
- KMID: 2373501
- Ann Lab Med.
- 2016 Jan;36(1):67-69.
- doi: 10.3343/alm.2016.36.1.67
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Resistance to the Tyrosine Kinase Inhibitor Imatinib (STI571) and Detection of BCR-ABL Gene Mutations in Korean Patients with Chronic Myeloid Leukemia
-
Sohn YH, Chi HS, Park CJ, Lee KH, Seo EJ
- KMID: 2252342
- Korean J Hematol.
- 2005 Jun;40(2):82-92.
- doi: 10.5045/kjh.2005.40.2.82
BACKGROUND: Imatinib mesylate, the tyrosine kinase activity of the BCR-ABL fusion gene, induces a remarkable remission in chronic myeloid leukemia (CML) patients. However, resistance to imatinib has been observed in... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Isolated Lymphoblastic Relapse of the Central Nervous System in a Patient with Chronic Myelogenous Leukemia Treated with Imatinib
-
Park MJ, Park PW, Seo YH, Kim KH, Seo JY, Jeong JH, Kim MJ, Jeong JW, Ahn JY, Park J
- KMID: 1791929
- Ann Lab Med.
- 2014 May;34(3):247-251.
- doi: 10.3343/alm.2014.34.3.247
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Straightforward Identification of Masked Polycythemia Vera Based on Proposed Revision of World Health Organization Diagnostic Criteria for BCR-ABL1-Negative Myeloproliferative Neoplasms
-
Chu D, Cho YU, Jang S, Seo EJ, Park CJ
- KMID: 2363272
- Ann Lab Med.
- 2015 Nov;35(6):651-653.
- doi: 10.3343/alm.2015.35.6.651
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Utility of the Multiplex Reverse Transcriptase-Polymerase Chain Reaction Assay in the Detection of Hematologic Malignancies
-
Kim MJ, Cho SY, Lee WI, Park TS, Lee HJ
- KMID: 1707242
- Ann Lab Med.
- 2013 Jul;33(4):304-307.
- doi: 10.3343/alm.2013.33.4.304
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Rapid Sequential Gain of ABL1 Kinase Domain Mutations with a Complex Karyotype in the Progression of Chronic Myelogenous Leukemia
-
Chung Y, Eom HS, Lee H, Park S, Shim H, Cho EH, Kong SY
- KMID: 1791958
- Ann Lab Med.
- 2014 Sep;34(5):399-401.
- doi: 10.3343/alm.2014.34.5.399
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
